ARES
Ares Management Corporation
There isn't enough reported data to score ARES yet.
MS
Morgan Stanley
MS's fundamentals are strong: revenue grew 16% and earnings per share grew 29%. At 15x earnings, it's trading in line with its usual 14x. Analysts expect earnings growth.
ARES Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Stable | |
| N/A | |
| N/A |
ARES's profitability is currently stable. There isn't enough data to rate its revenue. Free cash flow and net leverage aren't meaningful measures for financial services companies like ARES.
MS Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
MS's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like MS.
ARES PE Valuation
ARES has no meaningful PE right now: it lost money over the past year.
MS PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 11x | $134 | -29% |
| Fair | 14x | $178 | -5.7% |
| Forward | 14x | $189 | — |
| Current | 15x | $189 | — |
| Expensive | 18x | $223 | +18% |
Historical ranges are pointers, not guarantees.
MS's PE is in its fair range at 15x. If earnings grow as analysts expect, today's price would be 14x next year's earnings.
ARES Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Growth | |
| Strong growth | |
| Weakening | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for ARES, but weaker profitability.
MS Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
MS has the edge over ARES on the outlook, with more favorable profitability expectations.
ARES Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $6.53 | +220% |
| Q4 2024 | $2.04 | -16% |
| Q3 2024 | $2.20 | +1.4% |
| Q2 2024 | $1.95 | +18% |
| Q1 2024 | $2.26 | +102% |
| Q4 2023 | $2.42 | +178% |
| Q3 2023 | $2.17 | +136% |
| Q2 2023 | $1.65 | +3.8% |
| Q1 2023 | $1.12 | -46% |
MS has the stronger earnings trend. Trailing diluted EPS is down 16% for ARES versus MS up 29%.
MS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $13.39 | +6.3% |
| Q3 2026 | $12.60 | +29% |
| Q2 2026 | $12.37 | +40% |
| Q1 2026 | $11.04 | +29% |
| Q4 2025 | $10.21 | +28% |
| Q3 2025 | $9.76 | +48% |
| Q2 2025 | $8.84 | +45% |
| Q1 2025 | $8.53 | +55% |
| Q4 2024 | $7.95 | +53% |
MS's earnings per share have climbed steadily: $12.60 over the past year, up 29% from the year before, and higher year over year for 10 quarters in a row.
ARES Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q4 2024 | $1.2B | +11% |
| Q3 2024 | $842M | +24% |
| Q2 2024 | $874.9M | +11% |
| Q1 2024 | $735.8M | +13% |
| Q4 2023 | $1.1B | +0.7% |
| Q3 2023 | $677.7M | +12% |
| Q2 2023 | $785.1M | +28% |
| Q1 2023 | $653.7M | +18% |
ARES has the stronger quarterly revenue trend. Revenue is up 71% for ARES versus up 12% for MS.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 19% | N/A |
| Q4 2024 | 32% | -11 points |
| Q3 2024 | 39% | +5.4 points |
| Q2 2024 | 36% | -12 points |
| Q1 2024 | 31% | -5.5 points |
| Q4 2023 | 43% | +12 points |
| Q3 2023 | 33% | +44 points |
| Q2 2023 | 49% | +38 points |
ARES's operating margin was 19% last quarter, down 12 points from the same quarter a year ago.
MS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $20.3B | +12% |
| Q2 2026 | $21.3B | +27% |
| Q1 2026 | $20.6B | +16% |
| Q4 2025 | $17.9B | +10% |
| Q3 2025 | $18.2B | +18% |
| Q2 2025 | $16.8B | +12% |
| Q1 2025 | $17.7B | +17% |
| Q4 2024 | $16.2B | +26% |
MS's revenue has grown year over year for 14 quarters in a row: $20.3B last quarter, up 12% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 32% | -1.2 points |
| Q2 2026 | 34% | +6.9 points |
| Q1 2026 | 34% | +2.8 points |
| Q4 2025 | 32% | +2 points |
| Q3 2025 | 33% | +5.6 points |
| Q2 2025 | 28% | +0.4 points |
| Q1 2025 | 31% | +2.2 points |
| Q4 2024 | 30% | +14 points |
MS has the edge over ARES on profitability, with a higher operating margin.
ARES Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q4 2024 | $807.6M | +$1.4B |
| Q3 2024 | $841.3M | +164% |
| Q2 2024 | $432.2M | +$1.1B |
| Q1 2024 | $710M | +0.3% |
| Q4 2023 | -$560.1M | -$369.5M |
| Q3 2023 | $318.3M | +1194% |
| Q2 2023 | -$699.1M | +$93.3M |
| Q1 2023 | $707.6M | +216% |
ARES has the stronger cash trend. Its trailing FCF is up 484% versus its history, compared with MS at down 492%.
MS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$46B | -$42.7B |
| Q2 2026 | -$2.7B | -123% |
| Q1 2026 | -$7.1B | +$16.9B |
| Q4 2025 | -$2.4B | -120% |
| Q3 2025 | -$3.3B | +$14B |
| Q2 2025 | $11.8B | +368% |
| Q1 2025 | -$24B | -650% |
| Q4 2024 | $11.8B | +$29.6B |
MS's free cash flow was −$58.3B over the past year, against −$3.7B the year before. Free cash flow isn't a meaningful measure for financial services companies like MS.
ARES Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +15% | +47.1M shares |
| 1 year | +16% | +50.6M shares |
| 3 years | +23% | +66.9M shares |
| 5 years | +46% | +113M shares |
ARES has 360M diluted shares, up 16% from a year ago.
MS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.2% | -3M shares |
| 1 year | -1.5% | -24M shares |
| 3 years | -4.7% | -77M shares |
| 5 years | -14% | -246M shares |
| Available history | -4.5% | -74M shares |
MS has the edge over ARES on shareholder dilution, with a more favorable share count trend.
ARES Net Leverage
MS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 7.8x | High |
| Q2 2026 | 7.3x | High |
| Q1 2026 | 8.2x | High |
| Q4 2025 | 8.6x | High |
| Q3 2025 | 8.4x | High |
| Q2 2025 | 8.7x | High |
| Q1 2025 | 8.7x | High |
| Q4 2024 | 7.9x | High |
MS's net debt is about 7.8 years of its operating earnings (EBITDA), down from 8.4 years a year ago. Net leverage isn't a meaningful measure for financial services companies like MS.
ARES Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 54.0 | Neutral |
| Stochastic | 54.4 | Neutral |
ARES's weekly RSI is 54 (neutral) and its Stochastic is 54 (neutral).
MS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 45.0 | Neutral |
| Stochastic | 18.7 | Oversold |
MS's weekly RSI is 45 (neutral) and its Stochastic is 19 (oversold).
ARES PE vs Financial Services Sector
| Metric | ARES | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 13x | — |
ARES has no meaningful PE right now: it lost money over the past year.
MS PE vs Financial Services Sector
| Metric | MS | Sector median | Relative |
|---|---|---|---|
| PE | 15x | 13x | 15% above |
| PE % | 59 | 63 | 4 pts below |
MS is trading at 15x earnings, a 15% premium to the Financial Services sector's median of 13x.
ARES Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $123.3 | 8.1% above |
| 20 week MA | $128.3 | 3.9% above |
| 50 week MA | $130.7 | 2% above |
| 100 week MA | $148.9 | 10% below |
| 200 week MA | $134.3 | 0.7% below |
ARES has bounced recently, but its long-term trend is still down: it's above its 8-, 20- and 50-week averages, but 0.7% below its 200-week average.
MS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $186.5 | 1.5% above |
| 20 week MA | $203.3 | 6.9% below |
| 50 week MA | $191.9 | 1.4% below |
| 100 week MA | $164.9 | 15% above |
| 200 week MA | $129.3 | 46% above |
MS's trend is mixed: it's above three of its five weekly moving averages, and 46% above its 200-week average.
ARES Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $34.8 | $49.1 | +41% |
| 2021 | $49.1 | $81.4 | +66% |
| 2022 | $81.4 | $67.7 | -17% |
| 2023 | $67.7 | $118.9 | +76% |
| 2024 | $118.9 | $179.5 | +51% |
| 2025 | $179.5 | $168.7 | -6% |
| 2026 YTD | $168.7 | $133.3 | -21% |
ARES has finished higher in four of the last six years, three of them by more than 50%. It's down 21% so far in 2026.
MS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $51.1 | $68.1 | +33% |
| 2021 | $68.1 | $99.3 | +46% |
| 2022 | $99.3 | $86.1 | -13% |
| 2023 | $86.1 | $93.3 | +8.3% |
| 2024 | $93.3 | $126.8 | +36% |
| 2025 | $126.8 | $181.9 | +43% |
| 2026 YTD | $181.9 | $189.2 | +4% |
MS has the edge over ARES on returns for 2026, with the stronger performance.